Co-Diagnostics Ownership | Who Owns Co-Diagnostics?

Overview Forecast RevenueFinancials Chart Transcripts

Co-Diagnostics Ownership Summary

Co-Diagnostics is owned by 0.13% institutional investors, 7.83% insiders, and 92.04% retail investors. Vanguard group is the largest institutional shareholder, holding 5.83% of CODX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.01% of its assets in Co-Diagnostics shares.

CODX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Co-Diagnostics	0.13%	7.83%	92.04%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Medical Device Stocks	32.66%	10.50%	56.84%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.78M	5.83%	$1.33M
Private advisory group	1.18M	3.87%	$886.23K
Renaissance	555.62K	1.82%	$416.72K
Blackrock	502.02K	1.68%	$627.53K
Blackrock funding, inc. /de	504.24K	1.65%	$378.18K
Geode capital management	345.51K	1.13%	$259.21K
Bridgeway capital management	272.90K	0.89%	$204.68K
Susquehanna group, llp	259.13K	0.85%	$194.34K
Bank of new york mellon	137.07K	0.45%	$102.80K
Kestra advisory services	122.81K	0.40%	$92.11K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Private advisory group	1.18M	0.10%	$886.23K
Smi advisory services	28.00K	0.00%	$21.34K
Bridgeway capital management	272.90K	0.00%	$204.68K
Physician wealth advisors	28.38K	0.00%	$21.28K
Two sigma securities	16.46K	0.00%	$12.35K
Renaissance	555.62K	0.00%	$416.72K
Kestra advisory services	122.81K	0.00%	$92.11K
Group one trading	40.35K	0.00%	$30.27M
Global retirement partners	3.00K	0.00%	$2.25K
Tower research capital llc (trc)	6.23K	0.00%	$4.67K

Top Buyers

Holder	Shares	% Assets	Change
Private advisory group	1.18M	0.10%	1.18M
Susquehanna group, llp	259.13K	-	71.56K
Squarepoint ops	28.36K	-	28.36K
Geode capital management	345.51K	-	24.24K
Two sigma securities	16.46K	0.00%	16.46K

Top Sellers

Holder	Shares	% Assets	Change
Koss-olinger consulting	-	-	-58.10K
Thompson davis	-	-	-57.20K
D. e. shaw	-	-	-46.30K
Simplex trading	-	-	-27.52K
Xtx topco	-	-	-23.63K

New Positions

Holder	Shares	% Assets	Change	Value
Private advisory group	1.18M	0.10%	1.18M	$886.23K
Squarepoint ops	28.36K	-	28.36K	$21.27K
Goldman sachs group	15.99K	-	15.99K	$11.99K

Sold Out

Holder	Change
Qube research	-13.00
Financial network wealth advisors	-100.00
Northwestern mutual wealth management	-100.00
National bank of canada /fi/	-200.00
Fmr	-218.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	1	-97.67%	40,149	-99.30%	-	0.04%	1	-93.33%	-	-100.00%
Dec 31, 2024	43	7.50%	5,722,186	29.65%	18	8.96%	15	66.67%	9	-18.18%
Sep 30, 2024	39	-15.22%	4,402,641	-5.17%	14	5.97%	9	-57.14%	10	42.86%
Jun 30, 2024	46	12.20%	4,642,621	6.47%	15	7.05%	21	133.33%	7	-41.67%
Mar 31, 2024	41	-16.33%	4,360,457	-6.96%	14	5.83%	9	-35.71%	12	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.28M	4.01%	-
Vanguard Total Stock Mkt Idx Inv	1.28M	3.80%	-
Vanguard Institutional Extnd Mkt Idx Tr	444.78K	1.32%	-
Bridgeway Ultra-Small Company	272.90K	0.81%	-
Fidelity Extended Market Index	161.97K	0.48%	-3.99K
BlackRock Extended Equity Market K	72.43K	0.23%	-31.00
Extended Equity Market Fund K	71.67K	0.22%	220.00
iShares Micro-Cap ETF	62.55K	0.19%	-
Fidelity Total Market Index	53.05K	0.16%	-
Spartan Total Market Index Pool E	43.70K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 20, 2023	Brown Brian Lee	Chief Financial Officer	Buy	$5.70K
Sep 08, 2021	Durenard Eugene	-	Sell	$20.91K
May 19, 2021	BENSON REED L	General Counsel	Sell	$830.39K
May 19, 2021	BENSON REED L	General Counsel	Sell	$8.53
May 19, 2021	BENSON REED L	General Counsel	Sell	$93.23K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2023 Q4	-	-
2023 Q2	-	-
2023 Q1	1	-

CODX Ownership FAQ

Who Owns Co-Diagnostics?

Co-Diagnostics shareholders are primarily institutional investors at 0.13%, followed by 7.83% insiders and 92.04% retail investors. The average institutional ownership in Co-Diagnostics's industry, Medical Device Stocks, is 32.66%, which Co-Diagnostics falls below.

Who owns the most shares of Co-Diagnostics?

Co-Diagnostics’s largest shareholders are Vanguard group (1.78M shares, 5.83%), Private advisory group (1.18M shares, 3.87%), and Renaissance (555.62K shares, 1.82%). Together, they hold 11.53% of Co-Diagnostics’s total shares outstanding.

Does Blackrock own Co-Diagnostics?

Yes, BlackRock owns 1.68% of Co-Diagnostics, totaling 502.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 627.53K$. In the last quarter, BlackRock increased its holdings by 1.98K shares, a 0.40% change.

Who is Co-Diagnostics’s biggest shareholder by percentage of total assets invested?

Private advisory group is Co-Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 1.18M Co-Diagnostics shares, valued at 886.22K$.

Who is the top mutual fund holder of Co-Diagnostics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Co-Diagnostics shares, with 4.01% of its total shares outstanding invested in 1.28M Co-Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools